Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Insomnia, night sweats Respiratory: Asthma, allergies, sinus congestion Headaches Hair loss Body pain, joint pain Fatigue, low energy, weakness Mood swings, such as anxiety or depression
G allele odds ratio = 1.36)
As of mid-2024, there are five DOACs approved for use in the United States: Betrixaban (Bevyxxa) Rivaroxaban (Xarelto) Apixaban (Eliquis) Edoxaban (Savaysa) Dabigatran (Pradaxa) The mechanism(s) by which DOACs work differ from those of two other common anticoagulants: Warfarin inhibits clotting by acting as a vitamin K antagonist, and Heparin/low-molecular weight heparin works by activating antithrombin, which inactivates the coagulation enzymes thrombin, factor Xa, and factor IXa
Encyclopedia of Food and Health (Elsevier, 2016)
